Industry Verticals »

All Categories

Insights »

About TMR »

Roadside Drug Testing Devices Market Forecast, 2019 - 2027

Roadside Drug Testing Devices Market (Substance: Drugs [Tetrahydrocannabinol {THC}, Cocaine, Amphetamine, Benzodiazepines, Opioids, and Others] and Alcohol; Sample Type: Saliva, Sweat, Urine, and Others; and Modality: Handheld and Standalone) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Novel Roadside Handheld Devices Offer Convenience of Drug Detection

An alarming rate of deaths caused due to drink and drive scenarios are increasingly becoming a matter of concern for government authorities worldwide. Thus, innovations in the healthcare industry are generating incremental opportunities for companies in the roadside drug testing devices market. For instance, in December 2019, Abbott-a global leader in medical devices announced the launch of the SoToxa™ Mobile Test System, which is acquiring global recognition. Novel roadside drug testing devices are gaining importance to combat drug-impaired driving and ensure road safety.

Companies in the roadside drug testing devices market are increasing their production capabilities to develop handheld devices. This is evident since handheld modality segment is estimated for exponential growth during the forecast period and the global roadside drug testing devices market is expected to reach a value of ~US$ 924 Mn by the end of 2027. Stakeholders in law enforcement are using oral fluid swabs that are inserted in handheld analyzers to detect marijuana and other drugs within minutes.

roadside drug testing devices market infographic

Driving Simulators Help in Conducting Successful Clinical Trials

As suggested by the Swinburne University of Technology, drug users are apparently surpassing the number of alcohol consumers in Australia, resulting in high rates of fatal crashes. Hence, companies in the roadside drug testing devices market should tap opportunities in Australia to increase the uptake of detection devices. Likewise, companies in the market for roadside drug testing devices are collaborating with researchers to increase R&D in psychology and neurosciences to ascertain if drivers under the influence of cannabis are more likely to meet with an accident, as compared to alcohol consumers.

With the introduction of driving simulators, companies in the roadside drug testing devices market are able to conduct better analysis of cognitive behavior and psychomotor functioning of individuals through the help of clinical trials. Companies in the market for roadside drug testing devices are gaining important insights through research findings carried out as a result of collaborations between universities and medical institutes.

Breathalyzers with Nanotechnology Sensors a Gold Standard for Detection of THC

Breathalyzers are becoming increasingly mainstream in the detection of alcohol in the roadside drug testing devices market. However, there is a growing need for breathalyzers that are also capable of detecting marijuana. Hence, researchers in the market for roadside drug testing devices are increasing R&D to develop novel breathalyzers that detect THC. For instance, an interdisciplinary team at the University of Pittsburgh, developed a breathalyzer using nanotechnology sensors that detect THC. Thus, innovative breathalyzers are increasingly becoming the gold standard for THC detection and manufacturers should collaborate with researchers to innovate in devices. This trend has supported the exponential growth of THC among other substance types in the roadside drug testing devices market.

Companies in the roadside drug testing devices market are increasing research in developing breathalyzers using carbon nanotubes and nanotechnology sensors to meet requirements of mass spectrometry. This trend is prominent in the U.S. since legalization of recreational marijuana has raised concerns about the enforcement of DUI (Driving Under the Influence) laws in the region.

Innovations in THC Breathalyzers Generate Incremental Opportunities for Manufacturers

Since THC drugs segment is anticipated for exponential growth in the market for roadside drug testing devices, manufacturers are introducing breakthrough innovations that are a novel addition to the cannabis detection sector. For instance, Cannabix Technologies- a supplier of drug detection tools has announced that its scientific team has come up with a proprietary method-Field asymmetric waveform ion mobility spectrometry (FAIMS) to detect THC. Such innovations have contributed toward the modest of the roadside drug testing devices market, which is expected to expand at a CAGR of ~4% during the forecast period. Hence, manufacturers are focusing on innovating breathalyzers using high-field ion mobility and mass spectrometry.

Companies in the roadside drug testing devices market are developing lightweight devices that are user-friendly and store numerous samples. They are increasing efforts to develop devices that are capable of detecting extremely low quantities of THC analytes. Thus, innovative breathalyzers are increasingly replacing conventional breath analyzing techniques. 

roadside drug testing devices market segmentation

Analysts’ Viewpoint

The roadside drug testing devices market is projected for exponential growth in North America. Lack of efficient DUI laws in the U.S. are fueling the demand for drug testing devices. Manufacturers are increasing efforts to meet the demand for breath analyzers that can detect extremely low quantities of THC analytes.

Increased research spending has become the key focus point of companies in the market landscape. However, incidences of false positives from poppy seeds and tea in drug testing devices act as barriers for market growth. Hence, manufacturers should develop devices that can differentiate between drugs or alcohol and food items that are merely in the system of an individual.

Roadside Drug Testing Devices Market: Overview

  • According to Transparency Market Research’s latest research report on the global roadside drug testing devices market for the historical period of 2017–2018 and the forecast period of 2019–2027, increase in the number of drug and alcohol abusers and adoption of rapid test devices for screening or identification of drug and alcohol are anticipated to drive the global roadside drug testing devices market during the forecast period
  • According to the report, the global roadside drug testing devices market was valued at US$ 0.65 Bn in 2018. It is projected to expand at a CAGR of ~4% from 2019 to 2027.

Technological Advancements in Roadside Drug Testing Devices to Propel Market: A Key Driver

  • Roadside drug testing devices have already been adopted by the police force, with the introduction of a large number of new breathalyzer devices
  • Recent advancements by providers of drug, alcohol, and disease-testing products offer police with a robust set of roadside testing tools for the detection of alcohol and drug classes such as amphetamine, benzodiazepines, cannabis (THC), cocaine, methamphetamine, and opiates
  • New tests, such as paper spray mass spectrometry, analyze molecules in a fingerprint. As the body metabolizes a drug, it excretes molecules, which can (apparently) be detected in fingerprints by using the mass spectrometry method. The method works even after the hands are washed. Hence, there is no ‘coming clean’ with a quick trip to the sink. Researchers report 99% of accuracy rate by using this method.
  • Increase in the burden of drug and alcohol abuse and technological advancements have resulted in the adoption of portable roadside drug testing devices. Thus, rise in the demand for portable or handheld roadside drug testing devices is expected to propel the global roadside drug testing devices market during the forecast period.

Large Target Population

  • Increase in the number of drug and alcohol abusers across the world is expected to provide significant opportunities to test providers and manufacturers of drug abuse test products in the near future. According to the United Nations Office of Drug and Crime, over 5% of the global population aged between 15 and 64 years uses illicit drugs. Moreover, nearly 32.4 million people worldwide use pharmaceutical opioids and opiates such as opium or heroin.
  • According to the Centers for Disease Control and Prevention (CDC), around 4.7% of people aged 16 years or above in the U.S. are reported to be driving under the influence of marijuana and 0.9% are reported to be driving under the influence of illicit drugs other than marijuana.
  • Rise in target population and increase in government initiatives to control road accidents and fatalities in various countries are likely to drive the global roadside drug testing devices market during the forecast period

Inaccurate Results to Hamper Roadside Drug Testing Devices Market

  • Concerns about the efficacy and efficiency of roadside drug testing devices have increased over the last few years. For instance, in a study, which included over 300 Norway-based drivers who were tested for impairment by using both the oral device as well as the blood sample, it was found that the ratio of false-positive results generated by the device to findings of the blood sample was 14.5% for cannabis and 87.1% for cocaine.
  • Inaccurate results (false-positive or false-negative results) associated with roadside drug testing devices are projected to restrain the global roadside drug testing devices market during the forecast period

Roadside Drug Testing Devices Market: Competition Landscape

  • This report profiles major players operating in the global roadside drug testing devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The roadside drug testing devices market is moderately fragmented with the presence of a few large-scale players in the global market and some small-scale players in regional markets. The top four to five players hold a major share of the global roadside drug testing devices market.
  • Prominent players operating in the global roadside drug testing devices market are 
    • Drägerwerk AG & Co. KgaA
    • Abbott Laboratories
    • Oranoxis Inc.
    • CareHealth America
    • MAVAND Solutions GmbH
    • Pacific Data Systems Pty Ltd
    • Securetec, and UriTox, LLC

Roadside Drug Testing Devices Market: Key Developments

  • Key players operating in the global roadside drug testing devices market are engaged in the development and approval of new products, mergers and acquisitions, and collaborations. Major developments by key players operating in the global market are likely to fuel the global roadside drug testing devices market in the next few years. Some of the key developments in the global roadside drug testing devices market are as follows:
    • In October 2017, Abbott Laboratories acquired Alere, Inc. for approximately US$ 4.5 Bn. The acquisition strengthened the company’s product portfolio in the point of care testing devices and solutions segment. SoToxa, formerly known as the Alere DDS2 mobile test system, is able to generate test results indicating the presence of certain drugs in just five minutes. SoToxa is currently being used by law enforcement agencies in countries across the world including Canada, Germany, Spain, the U.K., and the U.S.
    • In September 2018, Securetec launched WipeAlyser, a mobile analysis device for use with the DrugWipe rapid drug screening test. DrugWipe itself is a highly precise saliva test for quick and safe detection of up to seven drug types.
    • In June 2019, Securetec developed the DrugWipe 2S saliva test for buprenorphine and methadone. The two active substances i.e. buprenorphine and methadone were used successfully to treat drug addiction.
  • The report on the global roadside drug testing devices market discusses individual strategies, followed by company profiles of manufacturers of roadside drug testing devices. The ‘Competition Landscape’ section has been included in the report to provide readers with a dashboard view and company market share analysis of key players operating in the global roadside drug testing devices market.

Frequently Asked Questions

What is the total market worth of roadside drug testing devices market?

Roadside drug testing devices market is expected to reach a value of ~US$ 924 Mn by the end of 2027

What is the anticipated CAGR of the roadside drug testing devices market in the forecast period?

Roadside drug testing devices market is projected to expand at a CAGR of ~4% from 2019 to 2027

What are the key driving factors for the growth of the roadside drug testing devices market?

Roadside drug testing devices market is driven by increase in the number of drug and alcohol abusers

Which region is expected to project the highest market share in the global roadside drug testing devices market?

North America accounted for a major share of the global roadside drug testing devices market

Who are the key players in the roadside drug testing devices market?

Key players in the global roadside drug testing devices market are Drägerwerk AG & Co. KgaA, Abbott Laboratories, Oranoxis, Inc., CareHealth America

1. Preface

   1.1. Market Definition and Scope

   1.2. Market Segmentation

   1.3. Key Research Objectives

   1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Roadside Drug Testing Devices Market 

4. Market Overview

   4.1. Introduction

       4.1.1.  Pricing Analysis

       4.1.2.  Industry Evolution/ Developments

   4.2. Overview

   4.3. Market Dynamics

       4.3.1. Drivers

       4.3.2. Restraints

   4.4. Global Roadside Drug Testing Devices Market Analysis and Forecast, 2017–2027

5. Market Outlook

   5.1. Technological Advancements 

   5.2. Roadside Drugs Testing Programs, by Country/Region

   5.3. Regulatory Scenario Assessment

   5.4. Key Industry Events (mergers, acquisitions, collaborations, launch & approvals, etc.)

6. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Modality 

   6.1. Introduction & Definition

   6.2. Key Findings / Developments

   6.3. Market Value Forecast, by Modality, 2017–2027

       6.3.1.  Handheld

       6.3.2. Standalone

   6.4. Market Attractiveness Analysis, by Modality 

7. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Substance 

   7.1. Introduction & Definition

   7.2. Key Findings / Developments

   7.3. Market Value Forecast, by Substance, 2017–2027

       7.3.1.  Drugs

           7.3.1.1. Tetrahydrocannabinol (THC)

           7.3.1.2. Cocaine

           7.3.1.3. Amphetamine

           7.3.1.4. Benzodiazepines

           7.3.1.5. Opioids

           7.3.1.6. Others

       7.3.2.  Alcohol

   7.4. Market Attractiveness Analysis, by Substance 

8. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Sample Type

   8.1. Introduction & Definition

   8.2. Key Findings / Developments

   8.3. Market Value Forecast, by Sample Type, 2017–2027

       8.3.1.  Saliva

       8.3.2. Sweat

       8.3.3. Urine

       8.3.4. Others

   8.4. Market Attractiveness Analysis, by Substance 

9. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Region

   9.1. Key Findings / Developments

   9.2. Market Value Forecast, by Region, 2017–2027

       9.2.1.  North America

       9.2.2. Europe

       9.2.3. Asia Pacific

       9.2.4. Latin America

       9.2.5. Middle East & Africa

   9.3. Market Attractiveness Analysis, by Region

10. North America Roadside Drug Testing Devices Market Analysis and Forecast

   10.1. Key Findings

   10.2. Market Value Forecast, by Modality, 2017–2027

       10.2.1.  Handheld

       10.2.2. Standalone

   10.3. Market Value Forecast, by Substance, 2017–2027

       10.3.1. Drugs

           10.3.1.1. Tetrahydrocannabinol (THC)

           10.3.1.2. Cocaine

           10.3.1.3. Amphetamine

           10.3.1.4. Benzodiazepines

           10.3.1.5. Opioids

           10.3.1.6. Others

       10.3.2. Alcohol

   10.4. Market Value Forecast, by Sample Type, 2017–2027

       10.4.1. Saliva

       10.4.2. Sweat

       10.4.3. Urine

       10.4.4. Others

   10.5. Market Attractiveness Analysis, by Country, 2017–2027

       10.5.1. U.S.

       10.5.2. Canada

   10.6. Market Attractiveness Analysis 

       10.6.1. By Modality 

       10.6.2. By Substance 

       10.6.3. By Sample Type 

       10.6.4. By Country

11. Europe Roadside Drug Testing Devices Market Analysis and Forecast

   11.1. Key Findings

   11.2. Market Value Forecast, by Modality, 2017–2027

       11.2.1.  Handheld

       11.2.2. Standalone

   11.3. Market Value Forecast, by Substance, 2017–2027

       11.3.1. Drugs

           11.3.1.1. Tetrahydrocannabinol (THC)

           11.3.1.2. Cocaine

           11.3.1.3. Amphetamine

           11.3.1.4. Benzodiazepines

           11.3.1.5. Opioids

           11.3.1.6. Others

       11.3.2. Alcohol

   11.4. Market Value Forecast, by Sample Type, 2017–2027

       11.4.1. Saliva

       11.4.2. Sweat

       11.4.3. Urine

       11.4.4. Others

   11.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027

       11.5.1. Germany

       11.5.2. U.K.

       11.5.3. France

       11.5.4. Italy

       11.5.5. Spain

       11.5.6. Rest of Europe

   11.6. Market Attractiveness Analysis 

       11.6.1. By Modality 

       11.6.2. By Substance 

       11.6.3. By Sample Type 

       11.6.4. By Country/Sub-region

12. Asia Pacific Roadside Drug Testing Devices Market Analysis and Forecast

   12.1. Key Findings

   12.2. Market Value Forecast, by Modality, 2017–2027

       12.2.1.  Handheld

       12.2.2. Standalone

   12.3. Market Value Forecast, by Substance, 2017–2027

       12.3.1. Drugs

           12.3.1.1. Tetrahydrocannabinol (THC)

           12.3.1.2. Cocaine

           12.3.1.3. Amphetamine

           12.3.1.4. Benzodiazepines

           12.3.1.5. Opioids

           12.3.1.6. Others

       12.3.2. Alcohol

   12.4. Market Value Forecast, by Sample Type, 2017–2027

       12.4.1. Saliva

       12.4.2. Sweat

       12.4.3. Urine

       12.4.4. Others

   12.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027

       12.5.1. China

       12.5.2. Japan

       12.5.3. India

       12.5.4. Australia & New Zealand

       12.5.5. Rest of Asia Pacific

   12.6. Market Attractiveness Analysis 

       12.6.1. By Modality 

       12.6.2. By Substance 

       12.6.3. By Sample Type 

       12.6.4. By Country/Sub-region

13. Latin America Roadside Drug Testing Devices Market Analysis and Forecast

   13.1. Key Findings

   13.2. Market Value Forecast, by Modality, 2017–2027

       13.2.1.  Handheld

       13.2.2. Standalone

   13.3. Market Value Forecast, by Substance, 2017–2027

       13.3.1. Drugs

           13.3.1.1. Tetrahydrocannabinol (THC)

           13.3.1.2. Cocaine

           13.3.1.3. Amphetamine

           13.3.1.4. Benzodiazepines

           13.3.1.5. Opioids

           13.3.1.6. Others

       13.3.2. Alcohol

   13.4. Market Value Forecast, by Sample Type, 2017–2027

       13.4.1. Saliva

       13.4.2. Sweat

       13.4.3. Urine

       13.4.4. Others

   13.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027

       13.5.1. Brazil

       13.5.2. Mexico

       13.5.3. Rest of Latin America

   13.6. Market Attractiveness Analysis 

       13.6.1. By Substance 

       13.6.2. By Substance 

       13.6.3. By Sample Type 

       13.6.4. By Country/Sub-region

14. Middle East & Africa Roadside Drug Testing Devices Market Analysis and Forecast

   14.1. Key Findings

   14.2. Market Value Forecast, by Modality, 2017–2027

       14.2.1.  Handheld

       14.2.2. Standalone

   14.3. Market Value Forecast, by Substance, 2017–2027

       14.3.1. Drugs

           14.3.1.1. Tetrahydrocannabinol (THC)

           14.3.1.2. Cocaine

           14.3.1.3. Amphetamine

           14.3.1.4. Benzodiazepines

           14.3.1.5. Opioids

           14.3.1.6. Others

       14.3.2. Alcohol

   14.4. Market Value Forecast, by Sample Type, 2017–2027

       14.4.1. Saliva

       14.4.2. Sweat

       14.4.3. Urine

       14.4.4. Others

   14.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027

       14.5.1. GCC Countries

       14.5.2. South Africa

       14.5.3. Rest of Middle East & Africa

   14.6. Market Attractiveness Analysis

       14.6.1. By Modality 

       14.6.2. By Substance 

       14.6.3. By Sample Type 

       14.6.4. By Country/Sub-region

15. Competition Landscape

   15.1. Market Player - Competition Matrix (By Tier and Size of companies)

   15.2. Market Share Analysis, by Company, 2018

   15.3. Company Profiles

       15.3.1. Abbott 

           15.3.1.1. Company Overview

           15.3.1.2. Company Financials

           15.3.1.3. Growth Strategies

           15.3.1.4. SWOT Analysis

       15.3.2. Drägerwerk AG & Co. KGaA. 

           15.3.2.1. Company Overview

           15.3.2.2. Company Financials

           15.3.2.3. Growth Strategies

           15.3.2.4. SWOT Analysis

       15.3.3. UriTox, LLC

           15.3.3.1. Company Overview

           15.3.3.2. Growth Strategies

           15.3.3.3. SWOT Analysis

       15.3.4. Oranoxis, Inc.

           15.3.4.1. Company Overview

           15.3.4.2. Growth Strategies

           15.3.4.3. SWOT Analysis

       15.3.5. Securetec

           15.3.5.1. Company Overview

           15.3.5.2. Growth Strategies

           15.3.5.3. SWOT Analysis

       15.3.6. CareHealth America

           15.3.6.1. Company Overview

           15.3.6.2. Growth Strategies

           15.3.6.3. SWOT Analysis

       15.3.7. MAVAND Solutions GmbH

           15.3.7.1. Company Overview

           15.3.7.2. Growth Strategies

           15.3.7.3. SWOT Analysis

       15.3.8. Pacific Data Systems Pty Ltd.

           15.3.8.1. Company Overview

           15.3.8.2. Growth Strategies

           15.3.8.3. SWOT Analysis

List of Tables

Table 01: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

Table 02: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 03: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

Table 04: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 05: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

Table 07: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 08: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

Table 09: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 10: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 11: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

Table 12: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 13: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

Table 14: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 15: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

Table 17: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 18: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

Table 19: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 20: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

Table 22: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 23: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

Table 24: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 25: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 26: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

Table 27: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 28: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

Table 29: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 30: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figures

Figure 01: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, 2017–2027

Figure 02: Global Roadside Drug Testing Devices Market Value Share, by Substance, 2018

Figure 03: Global Roadside Drug Testing Devices Market Value Share, by Sample Type, 2018

Figure 04: Global Roadside Drug Testing Devices Market Value Share, by Modality, 2018

Figure 05: Global Roadside Drug Testing Devices Market Value Share, by Region, 2018

Figure 06: Global Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

Figure 07: Global Roadside Drug Testing Devices Market Value Share Analysis, by Drugs, 2018 and 2027

Figure 08: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Drugs, 2019–2027

Figure 09: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs,

Figure 10: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Alcohol, 2017–2027

Figure 11: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Tetrahydrocannabinol (THC), 2017–2027

Figure 12: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cocaine, 2017–2027

Figure 13: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Amphetamine, 2017–2027

Figure 14: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Benzodiazepines, 2017–2027

Figure 15: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Opioids, 2017–2027

Figure 16: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 17: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

Figure 18: Global Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 19: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Saliva, 2017–2027

Figure 20: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 21: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urine, 2017–2027

Figure 22: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Sweat, 2017–2027

Figure 23: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

Figure 24: Global Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

Figure 25: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Handheld, 2017–2027

Figure 26: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Standalone, 2017–2027

Figure 27: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

Figure 28: Global Roadside Drug Testing Devices Market Value Share Analysis, by Region, 2018 and 2027

Figure 29: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Region, 2019–2027

Figure 30: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 31: North America Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

Figure 32: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

Figure 33: North America Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 34: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

Figure 35: North America Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

Figure 36: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

Figure 37: North America Roadside Drug Testing Devices Market Value Share Analysis, by Country, 2018 and 2027

Figure 38: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Country, 2019–2027

Figure 39: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 40: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

Figure 41: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

Figure 42: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 43: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

Figure 44: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

Figure 45: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

Figure 46: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 47: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 48: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 49: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

Figure 50: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

Figure 51: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 52: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

Figure 53: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

Figure 54: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

Figure 55: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 56: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 57: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 58: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

Figure 59: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

Figure 60: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 61: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

Figure 62: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

Figure 63: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

Figure 64: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 65: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 66: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 67: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

Figure 68: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

Figure 69: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 70: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

Figure 71: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

Figure 72: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

Figure 73: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region,

Figure 74: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 75: Global Roadside Drugs Testing Devices Analysis, by Top Company Ranking, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved

Roadside Drug Testing Devices Market Forecast, 2019 - 2027

Schedule a Call